Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H28N8O2 |
InChIKeySSZHESNDOMBSRV-UHFFFAOYSA-N |
CAS Registry1059070-10-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 01 Feb 2013 |